862907-48-0
862907-48-0
Chemical Structure
AH3960
- CAS No.: 862907-48-0
- Formula:C13H22N4O3
- Molecular Weight:282.34
IUPAC Name: 1,3-dibutyl-5-(diaminomethylene)pyrimidine-2,4,6(1H,3H,5H)-trione
InChIKey: KTVAHYZLKKQAOW-UHFFFAOYSA-N
SMILES: O=C1/C(C(N(CCCC)C(N1CCCC)=O)=O)=C(N)\N
Biological Activity: AH3960 (compound 16c) is an antagonist of androgen receptor. AH3960 binds wild as well as T877 mutant type androgen receptors. AH3960 selectively inhibits T877 with an IC50 value of 0.82 μM. AH3960 also serves as an agonist of parathyroid hormone receptor-1 (PTHR1)[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AH3960 | 99.92% | AH3960 (compound 16c) is an antagonist of androgen receptor. AH3960 binds wild as well as T877 mutant type androgen receptors. AH3960 selectively inhibits T877 with an IC50 value of 0.82 μM. AH3960 also serves as an agonist of parathyroid hormone receptor-1 (PTHR1). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Structural Analogs
-
Similarity Score 0.70
HY-121350Merodantoin -
Similarity Score 0.61
HY-151725N3-Pen-Dtpp -
Similarity Score 0.59
HY-W0170611,6-Bismaleimidohexane -
Similarity Score 0.58
HY-W0119571,4-Bis-maleimidobutane -
Similarity Score 0.56
HY-W73941111-Maleimidoundecanoic acid hydrazide -
Similarity Score 0.56
HY-13090811-Maleimidoundecanoic acid -
Similarity Score 0.55
HY-W591975Alkyne maleimide -
Similarity Score 0.55
HY-Z3579Oseltamivir impurity 68 -
Similarity Score 0.55
HY-W800648Mal-PEG2-amide -
Explore the MedChemAI to find more analogs
References
- [1]. Yamamoto S, et al. Design, synthesis, and biological evaluation of 4-arylmethyl-1-phenylpyrazole and 4-aryloxy-1-phenylpyrazole derivatives as novel androgen receptor antagonists. Bioorg Med Chem. 2012 Apr 1;20(7):2338-52. [Content Brief]
- [2]. Carter PH, et al. Actions of the small molecule ligands SW106 and AH-3960 on the type-1 parathyroid hormone receptor. Mol Endocrinol. 2015 Feb;29(2):307-21. [Content Brief]
